Inventor · disambiguated record
Alexander Hillisch
Also filed as: HILLISCH ALEXANDER
41 granted patents·32 pending applications·353 citations·filing 2000–2025
97Inventor score
Top patents by PatentIndex Score
73 records- 0196US7534780B2Estradiol prodrugsBAYER SCHERING PHARMA AG·Filed 2005·Granted May 19, 2009·59 cites·26 claims
- 0295US6958327B118 Norsteroids as selectively active estrogensSCHERING AG·Filed 2000·Granted Oct 25, 2005·88 cites·35 claims
- 0392US7414043B29-α-substituted estratrienes as selectively active estrogensSCHERING AG·Filed 2003·Granted Aug 19, 2008·56 cites·26 claims
- 0490US7378404B28β-hydrocarbyl-substituted estratrienes for use as selective estrogensSCHERING AG·Filed 2001·Granted May 27, 2008·52 cites·41 claims
- 0589US9822102B2Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disordersBayer Pharma AG·Filed 2016·Granted Nov 21, 2017·7 cites·7 claims
- 0688US9434690B2Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disordersBayer Pharma AG·Filed 2014·Granted Sep 6, 2016·10 cites·8 claims
- 0787US10183932B2Substituted oxopyridine derivatives and use thereof cardiovascular disordersBayer Pharma AG·Filed 2017·Granted Jan 22, 2019·5 cites·8 claims
- 0886US10077265B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2015·Granted Sep 18, 2018·4 cites·14 claims
- 0985US10421742B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2016·Granted Sep 24, 2019·3 cites·9 claims
- 1085US7678804B2Pyrimidine derivatives for treatment of hyperproliferative disordersBAYER HEALTHCARE LLC·Filed 2005·Granted Mar 16, 2010·4 cites·11 claims
- 1184US9475809B2Substituted oxopyridine derivatives and use thereof as factor xia/plasmaBayer Pharma AG·Filed 2014·Granted Oct 25, 2016·6 cites·7 claims
- 1282US10071995B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2015·Granted Sep 11, 2018·3 cites·15 claims
- 1381US10138236B2Factor xia-inhibiting pyridobenzazepine and pyridobenzazocine derivativesBayer Pharma AG·Filed 2015·Granted Nov 27, 2018·4 cites·15 claims
- 1479US9765070B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2014·Granted Sep 19, 2017·4 cites·9 claims
- 1579US6956031B211β-Substituted 19-nor-17-α-pregna-1,3,5(10)-trien-17β-ols with a 21,16α-lactone ringSCHERING AG·Filed 2003·Granted Oct 18, 2005·12 cites·17 claims
- 1678US10167280B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2015·Granted Jan 1, 2019·2 cites·16 claims
- 1778US9918969B2Substituted oxopyridine derivatives and use thereof as factor XIa/plasmaBayer Pharma AG·Filed 2016·Granted Mar 20, 2018·2 cites·3 claims
- 1877US2025282748A1Substituted oxopyridine derivativesBayer Pharma AG·Filed 2025·Application pending·0 cites
- 1976US7550451B2Progesterone receptor modulators with increased antigonadotropic activity for female birth control and hormone replacement therapyBAYER SCHERING PHARMA AG·Filed 2003·Granted Jun 23, 2009·10 cites·24 claims
- 2074US11912692B2Substituted S-alaninate derivativesBAYER AG·Filed 2023·Granted Feb 27, 2024·0 cites·17 claims
- 2174US7427610B22-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour actionSTERIX LTD·Filed 2004·Granted Sep 23, 2008·8 cites·21 claims
- 2273US10414731B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2015·Granted Sep 17, 2019·1 cites·6 claims
- 2371US2023024752A1Substituted oxopyridine derivativesBayer Pharma AG·Filed 2021·Application pending·0 cites
- 2470US7582645B2Pyrimidine derivatives for treatment of hyperproliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 1, 2009·4 cites·10 claims
- 2569US8183246B2Acyclically substituted furopyrimidine derivatives and use thereofLAMPE THOMAS·Filed 2006·Granted May 22, 2012·1 cites·9 claims
- 2669US7419972B22-substituted estra-1,3,5(10)-trien-17-ones as inhibitors of 17β-hydroxy steroid dehydrogenase type 1SCHERING AG·Filed 2005·Granted Sep 2, 2008·2 cites·26 claims
- 2767US11180471B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2019·Granted Nov 23, 2021·0 cites·67 claims
- 2867US7507725B2Compounds with sulphonamide group and pharmaceutical compositions containing these compoundsSCHERING AG·Filed 2001·Granted Mar 24, 2009·4 cites·18 claims
- 2967US2010075967A1Pyrimidine derivatives for treatment of hyperproliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2009·Application pending·0 cites
- 3063US2025002483A1Substituted s-alaninate derivativesBAYER AG·Filed 2022·Application pending·0 cites
- 3162US7244762B2Antitumoral d-homoestra-1,3,5 (10)-trien-3-yl 2-substituted sulfamatesSTERIX LTD·Filed 2004·Granted Jul 17, 2007·1 cites·24 claims
- 3260US7732493B22-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1BAYER SCHERING PHARMA AG·Filed 2008·Granted Jun 8, 2010·0 cites·13 claims
- 3357US6855836B217-Methylene steroids, process for their production and pharmaceutical compositions that contain these compoundsJENAPHARM GMBH·Filed 2001·Granted Feb 15, 2005·1 cites·25 claims
- 3457US2011201564A1Substituted 7-sulfanylmethyl, 7-sulfinylmethyl and 7-sulfonylmethyl indoles and use thereofBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 3556US2008132476A1Substituted estratrienes as selectively active estrogensKOSEMUND DIRK·Filed 2008·Application pending·0 cites
- 3655US8492570B22-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumor actionHILLISCH ALEXANDER·Filed 2008·Granted Jul 23, 2013·0 cites·5 claims
- 3754US2008182829A18Beta-Hydrocarbyl-Substituted Estratrienes As Selectively Active EstrogensPETERS OLAF·Filed 2008·Application pending·0 cites
- 3852US8063234B2Substituted 7-sulfanylmethyl-, 7-sulfinylmethyl- and 7-sulfonylmethylindoles and the use thereofKOLKHOF PETER·Filed 2009·Granted Nov 22, 2011·0 cites·26 claims
- 3952US7250408B2Glucocorticoid receptor antagonists for prophylaxis and therapy of glucocorticoid-mediated hypogonadism, of sexual dysfunction and/or infertilityBAYER SCHERING PHARMA AG·Filed 2003·Granted Jul 31, 2007·0 cites·10 claims
- 4052US2009023896A1Compounds with a sulphonamide group and pharmaceutical compositions containing these compoundsELGER WALTER·Filed 2008·Application pending·0 cites
- 4151USRE42132EAntitumoral D-homoestra-1,3,5(10)-trien-3-yl 2-substituted sulfamatesSTERIX LTD·Filed 2004·Granted Feb 8, 2011·0 cites·25 claims
- 4250US7435757B22-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1SCHERING AG·Filed 2005·Granted Oct 14, 2008·0 cites·13 claims
- 4350US2003130249A1Therapeutic use of estrogen receptor (ER)beta-selective agonists for triggering somatotropic, organotropic and anticatabolic effects (somatotropic therapy)SCHERING AG·Filed 2002·Application pending·0 cites
- 4450US2011183928A13-Cyanoalkyl- and 3-hydroxyalkylindoles and use thereofBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 4548US8026229B2Antitumor-active 2-alkoxyestradiol sulfamatesSTERIX LTD·Filed 2002·Granted Sep 27, 2011·0 cites·21 claims
- 4648US2010022527A1Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral diseasesAICURIS GMBH & CO KG·Filed 2009·Application pending·0 cites
- 4747US7199115B217α-fluorosteroids, pharmaceutical compositions containing 17α-fluorosteroids and a method of making themSCHERING AG·Filed 2005·Granted Apr 3, 2007·0 cites·8 claims
- 4846US7119082B211β-long-chain-substituted 19-nor-17α-pregna-1,3,5(10)-trien-17β-ols with a 21,16α-lactone ringSCHERING AG·Filed 2003·Granted Oct 10, 2006·0 cites·20 claims
- 4946US2007197488A1Prodrugs of ERbeta-selective substances, process for their production, and pharmaceutical compositions that contain these compoundsPETERS OLAF·Filed 2006·Application pending·0 cites
- 5045US9493472B2Substituted benzoxazolesBayer Pharma AG·Filed 2014·Granted Nov 15, 2016·0 cites·17 claims
Showing the top 50 of 73 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Alexander Hillisch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →